Aspirin and Dipyridamole
Aspirin and Dipyridamole is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including Aspirin and Dipyridamole. Available dosage form: capsule, extended release.
Drug Details
- Generic Name
- Aspirin and Dipyridamole
- Brand Names
- Aspirin and Dipyridamole
- Application Number
- ANDA209048
- Sponsor
- Dr. Reddy's Laboratories Inc
- NDC Codes
- 2
- Dosage Forms
- CAPSULE, EXTENDED RELEASE
- Routes
- ORAL
- Active Ingredients
- ASPIRIN, DIPYRIDAMOLE
Indications and Usage
1 INDICATIONS AND USAGE Aspirin and extended-release dipyridamole capsules are indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis. Aspirin and extended-release dipyridamole capsules are a combination of aspirin and dipyridamole, antiplatelet agents, indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis ( 1 )